-
公开(公告)号:US20050176821A1
公开(公告)日:2005-08-11
申请号:US10657570
申请日:2003-09-08
IPC分类号: A61K31/00 , A61K31/195 , A61K31/415 , A61K31/4164 , A61K31/4168 , A61K31/44 , A61K31/445 , A61P3/00 , A61P3/14 , A61P9/00 , A61P9/10 , A61P35/00 , A61P35/04 , A61P43/00 , C07C311/42 , C07C311/46 , C07C311/47 , C07D211/96 , C07D213/55 , C07D233/50 , C07D295/26 , A61K31/277 , A61K31/18
CPC分类号: C07D295/26 , C07C311/42 , C07C311/46 , C07C311/47 , C07D211/96 , C07D213/55 , C07D233/50
摘要: The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3 integrin.
摘要翻译: 本发明涉及一类由式I表示的化合物或其药学上可接受的盐,包含式I化合物的药物组合物和选择性抑制或拮抗α > 3 sub>整联蛋白。
-
公开(公告)号:US5843906A
公开(公告)日:1998-12-01
申请号:US824626
申请日:1997-03-27
IPC分类号: A61K31/00 , A61K31/195 , A61K31/415 , A61K31/4164 , A61K31/4168 , A61K31/44 , A61K31/445 , A61P3/00 , A61P3/14 , A61P9/00 , A61P9/10 , A61P35/00 , A61P35/04 , A61P43/00 , C07C311/42 , C07C311/46 , C07C311/47 , C07D211/96 , C07D213/55 , C07D233/50 , C07D295/26 , A61K38/00
CPC分类号: C07D295/26 , C07C311/42 , C07C311/46 , C07C311/47 , C07D211/96 , C07D213/55 , C07D233/50
摘要: The present invention relates to a class of compounds represented by the Formula I ##STR1## or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the .alpha..sub.v .beta..sub.3 integrin.
摘要翻译: 本发明涉及一类由式I表示的化合物或其药学上可接受的盐,包含式I化合物的药物组合物和选择性抑制或拮抗αvβ3整联蛋白的方法。
-
公开(公告)号:US06677308B1
公开(公告)日:2004-01-13
申请号:US09141547
申请日:1998-08-28
IPC分类号: A61K3800
CPC分类号: C07D295/26 , C07C311/42 , C07C311/46 , C07C311/47 , C07D211/96 , C07D213/55 , C07D233/50
摘要: The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the &agr;v&bgr;3 integrin.
摘要翻译: 本发明涉及一类由式I表示的化合物或其药学上可接受的盐,包含式I化合物的药物组合物,以及选择性抑制或拮抗阿尔茨海因3整联蛋白的方法。
-
-